204 related articles for article (PubMed ID: 33795826)
1. Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients.
Cho Y; Lee J; Lee IJ; Kim JW; Baek JG; Jung DM; Cho BC; Hong MH; Kim HR; Lee CG; Yoon HI
Sci Rep; 2021 Apr; 11(1):7435. PubMed ID: 33795826
[TBL] [Abstract][Full Text] [Related]
2. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
[TBL] [Abstract][Full Text] [Related]
3. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
Kundapur V; Ellchuk T; Ahmed S; Gondi V
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
[TBL] [Abstract][Full Text] [Related]
4. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
5. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
[TBL] [Abstract][Full Text] [Related]
6. Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary?
Farris MK; Wheless WH; Hughes RT; Soike MH; Masters AH; Helis CA; Chan MD; Cramer CK; Ruiz J; Lycan T; Petty WJ; Ahmed T; Leyrer CM; Blackstock AW
Pract Radiat Oncol; 2019 Nov; 9(6):e599-e607. PubMed ID: 31271904
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
[TBL] [Abstract][Full Text] [Related]
9. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891
[TBL] [Abstract][Full Text] [Related]
10. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
[TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
Bang A; Kendal WS; Laurie SA; Cook G; MacRae RM
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1133-1140. PubMed ID: 29908788
[TBL] [Abstract][Full Text] [Related]
13. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
14. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
Korkmaz Kirakli E; Oztekin O
Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
[TBL] [Abstract][Full Text] [Related]
15. Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review.
Fairchild A; Guest N; Letcher A; Mazure B; Ghosh S; Gabos Z; Chu KP; Debenham B; Nijjar T; Severin D; Scrimger R; Roa W; Yee D
J Med Imaging Radiat Sci; 2020 Mar; 51(1):75-87.e2. PubMed ID: 31759940
[TBL] [Abstract][Full Text] [Related]
16. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
17. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
Ozawa Y; Omae M; Fujii M; Matsui T; Kato M; Sagisaka S; Asada K; Karayama M; Shirai T; Yasuda K; Nakamura Y; Inui N; Yamada K; Yokomura K; Suda T
BMC Cancer; 2015 Aug; 15():589. PubMed ID: 26275617
[TBL] [Abstract][Full Text] [Related]
18. Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12).
Vees H; Caparrotti F; Eboulet EI; Xyrafas A; Fuhrer A; Meier U; Mark M; Elicin O; Aebersold DM; Zwahlen DR; Finazzi T; Allal AS; Putora PM; Martucci F; Rudolf CB; Ribi K;
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):279-287. PubMed ID: 32142869
[TBL] [Abstract][Full Text] [Related]
19. The impact of prophylactic cranial irradiation for post-operative patients with limited stage small cell lung cancer.
Chen MY; Hu X; Xu YJ; Chen M
Medicine (Baltimore); 2018 Nov; 97(44):e13029. PubMed ID: 30383664
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]